Diet, Inflammation, and Glycemic Control in Type 2 Diabetes: An Integrative Review of the Literature
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes (T2D) is a growing national health problem affecting 35% of adults ≥20 years of age in the United States. Recently, diabetes has been categorized as an inflammatory disease, sharing many of the adverse outcomes as those reported from cardiovascular disease. Medical nutrition therapy is recommended for the treatment of diabetes; however, these recommendations have not been updated to target the inflammatory component, which can be affected by diet and lifestyle. To assess the current state of evidence for which dietary programs contain the most anti-inflammatory and glycemic control properties for patients with T2D, we conducted an integrative review of the literature. A comprehensive search of the PubMed, CINAHL, Scopus, and Web of Science databases from January 2000 to May 2012 yielded 786 articles. The final 16 studies met the selection criteria including randomized control trials, quasiexperimental, or cross-sectional studies that compared varying diets and measured inflammatory markers. The Mediterranean and DASH diets along with several low-fat diets were associated with lower inflammatory markers. The Mediterranean diet demonstrated the most clinically significant reduction in glycosylated hemoglobin (HbA 1c). Information on best dietary guidelines for inflammation and glycemic control in individuals with T2D is lacking. Continued research is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Trials · doi:10.1186/1745-6215-11-32 · Cited by 1,871
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.02.005 · Cited by 1,022
Dietary fat intake and risk of type 2 diabetes in women
Salmerón, J., Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Rimm, E. B., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1019 · Cited by 818
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study
Liu, S., Stampfer, M. J., Hu, F. B., Giovannucci, E., Rimm, E., Manson, J. E., Hennekens, C. H., & Willett, W. C. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.412 · Cited by 774 · cited 1×
“For example, in large prospective studies, whole grain intake has been associated with both decreased inflammatory markers [37] and decreased incidence of T2D [38].”
BackgroundDiabetes and Cardiovascular Disease: The “Common Soil” Hypothesis
Stern, M. P. (1995) · Diabetes · doi:10.2337/diab.44.4.369 · Cited by 739 · cited 1×
“Inflammation is present prior to the development of T2D and cardiovascular disease (CVD), contributing to evidence to support the “common soil” hypothesis, which is a reference to the common risk factors for the development of these two diseases [6].”
BackgroundBarnard, N. D., Cohen, J., Jenkins, D. J., Turner-McGrievy, G., Gloede, L., Green, A., & Ferdowsian, H. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.26736h · Cited by 449 · cited 6×
“01 for each group) but a nonsignificant difference between the two diet groups [24], perhaps due to the similar macronutrient content of the two dietary interventions.”
BackgroundMethodResultInfluentialWolever, T. M., Gibbs, A. L., Mehling, C., Chiasson, J.-L., Connelly, P. W., Josse, R. G., Leiter, L. A., Maheux, P., Rabasa-Lhoret, R., Rodger, N. W., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.114 · Cited by 333
Salas-Salvadó, J., Garcia-Arellano, A., Estruch, R., Marquez-Sandoval, F., Corella, D., Fiol, M., Gómez-Gracia, E., Viñoles, E., Arós, F., Herrera, C., et al. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602762 · Cited by 295 · cited 27×
“Similarly, Davis et al. [26] demonstrated that after following an intervention of either a low-fat or low-carbohydrate diet for 24 weeks, CRP was only found to be significantly reduced in the lowfat diet arm (P = .01) and not in the low-carbohydrate arm (P = .94).”
ResultInfluential
Research works printed but not linked: 30
- 10.1177/0884533610386234 · DOI · Paper page
- 2000, Obesity Reviews, 1, 57, 10.1046/j.1467-789x.2000.00013.x · DOI · Paper page
- 10.2337/dc09-1679 · DOI · Paper page
- 2003, Diabetes, 52, 1799, 10.2337/diabetes.52.7.1799 · DOI · Paper page
- 10.1177/0193945909356556 · DOI
- 10.1136/bmj.39561.501007.BE · DOI · Paper page
- 10.1016/j.numecd.2008.11.009 · DOI · Paper page
- 10.1080/17482970701737285 · DOI
- 10.1111/j.1464-5491.2006.01886.x · DOI · Paper page
- 2010, Diabetes, Metabolic Syndrome and Obesity, 3, 357, 10.2147/DMSO.S13966 · doi:10.2147/dmso.s13966
- 10.3945/jn.110.136739 · DOI · Paper page
- 10.1007/s00592-011-0318-5 · DOI
- 10.1053/j.jrn.2010.01.009 · DOI
- 10.1210/jc.2010-1858 · DOI · Paper page
- 10.1016/j.jdiacomp.2011.08.001 · DOI
- 10.1016/j.metabol.2005.01.033 · DOI · Paper page
- 10.1111/j.1743-6109.2011.02417.x · DOI · Paper page
- 10.1111/j.1365-2648.2005.03621.x · DOI · Paper page
- 1999, British Journal of Nutrition, 81, S71, 10.1017/S0007114599000926 · doi:10.1017/s0007114599000926
- 10.1017/S0007114508143562 · DOI · Paper page
- 2002, American Journal of Clinical Nutrition, 76, 535, 10.1093/ajcn/76.3.535 · DOI · Paper page
- 2004, Journal of Nutrition, 134, 1806, 10.1093/jn/134.7.1806 · DOI · Paper page
- 2002, Diabetes Care, 25, S28, 10.2337/diacare.25.2007.S28 · DOI · Paper page
- 10.1016/j.nut.2008.04.005 · DOI · Paper page
- 10.2337/diacare.25.3.425 · DOI · Paper page
- 10.1016/j.apnr.2007.05.004 · DOI
- 10.1007/s11883-008-0069-0 · DOI
- 2010, Journal of Clinical Epidemiology, 63, 813, 10.1016/j.jclinepi.2010.01.002 · DOI
- 10.1038/oby.2008.224 · DOI · Paper page
- 10.1016/j.phrs.2011.07.004 · DOI · Paper page
Cited by
Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome
Roberts, L. D., Koulman, A., & Griffin, J. L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70143-8 · Cited by 263
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Jin, Q., & Ma, R. C. W. (2021) · Cells · doi:10.3390/cells10112832 · Cited by 252
Laouali, N., Mancini, F. R., Hajji-Louati, M., El Fatouhi, D., Balkau, B., Boutron-Ruault, M.-C., Bonnet, F., & Fagherazzi, G. (2019) · Diabetologia · doi:10.1007/s00125-019-04972-0 · Cited by 101
Adjibade, M., Andreeva, V. A., Lemogne, C., Touvier, M., Shivappa, N., Hébert, J. R., Wirth, M. D., Hercberg, S., Galan, P., Julia, C., et al. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.245167 · Cited by 91
Metadata
- Authors
- Nowlin, S. Y., Hammer, M. J., & D'Eramo Melkus, G.
- Venue
- Journal of Nutrition and Metabolism
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-21
- ISSN
- 2090-0724 (ISSN-L)
- 2090-0732
- OpenAlex
- W2091593051
- Cited by
- 71
- References
- 14
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diet, Inflammation, and Glycemic Control in Type 2 Diabetes: An Integrative Review of the Literature. https://app.cochat.ai/papers/10.1155/2012/542698
- The paper
- Nowlin, S. Y., Hammer, M. J., & D'Eramo Melkus, G. (2012). Diet, Inflammation, and Glycemic Control in Type 2 Diabetes: An Integrative Review of the Literature. Journal of Nutrition and Metabolism. https://doi.org/10.1155/2012/542698
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.